Treatment of hypoactive sexual desire disorder in premenopausal women: Efficacy of flibanserin in the DAISY study

Journal of Sexual Medicine

Volumn 9, Issue 3, 2012, Pages 793-804

  Thorp, John ^a   Simon, James ^b   Dattani, Dan ^c   Taylor, Leslie ^d   Kimura, Toshio ^e   Garcia, Miguel ^e   Lesko, Lynna ^e   Pyke, Robert ^e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Prairie Clinical Research Group   (Canada)

^d Dean Foundation for Health Research and Education   (United States)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Desire; Distress; Flibanserin; HSDD; Hypoactive sexual desire disorder; Premenopausal women

Indexed keywords

FLIBANSERIN; PLACEBO;

ADULT; AMERICAN INDIAN; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MAJOR CLINICAL STUDY; NAUSEA; PREMENOPAUSE; PRIORITY JOURNAL; RHINOPHARYNGITIS; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84857644003     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02595.x     Document Type: Article

References (22)

1. American Psychiatric Association. Diagnostic and statistical manual of mental Disorders. 4th edition, text revision. Washington, DC: American Psychiatric Press; 2000.
2. Hatzichristou D, Rosen RC, DeRogatis LR, Low WY, Meuleman EJ, Sadovsky R, Symonds T. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 2010;7(1 Pt 2):337-48.
3. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009;6:1549-60.
4. Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: Current status and future directions. J Sex Res 2009;46:121-42.
5. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
6. Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S. Pharmacology of flibanserin. CNS Drug Rev 2002;8:117-42.
7. Kennedy SH. Flibanserin: Initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. J Sex Med 2010;7:3449-59.
8. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-72.
9. Beck AT, Steer RA, Brown G. Manual for Beck Depression Inventory-II. San Antonio, TX: The Psychological Corporation; 1996.
10. DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008;5:357-64.
11. Clayton AH, Goldmeier D, Nappi RE, Lewis-D'Agostino DJ, Wunderlich G, Pyke R. Validation of the sexual interest and desire inventory-female (SIDI-F) in hypoactive sexual desire disorder. J Sex Med 2010;7:3918-28.
12. Beck AT, Steer RA. Manual for Beck Scale for Suicide Ideation. San Antonio, TX: The Psychological Corporation; 1991.
13. US Food and Drug Administration. Draft guidance for industry. Female Sexual Dysfunction: Clinical development of drug products for treatment. 2000. Available at: (accessed June 6, 2011).
14. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
15. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 2003;29:39-46.
16. Revicki D, Margolis MK, Bush EN, DeRogatis L, Hanes V. Content validity of the Female Sexual Function Index (FSFI) in pre- and post-menopausal women with hypoactive sexual desire disorder (HSDD). J Sex Med 2011;8:2237-45.
17. DeRogatis L, Pyke R, McCormack J, Hunter A, Harding G. Does the Female Sexual Distress Scale-Revised (FSDS-R) cover the feelings of women with HSDD? J Sex Med 2011;8:2810-5.
18. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2.
19. Allers KA, Dremencov E, Ceci A, Flik G, Ferger B, Cremers TI, Ittrich C, Sommer B. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: A microdialysis study. J Sex Med 2010;7:1757-67.
20. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011;8:15-27.
21. Clayton AH, Dennerstein L, Fisher WA, Kingsberg SA, Perelman MA, Pyke RE. Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment. J Sex Med 2010;7(1 Pt 2):541-60.
22. Witting K, Santtila P, Varjonen M, Jern P, Johansson A, von der Pahlen B, Sandnabba K. Female Sexual Dysfunction, sexual distress, and compatibility with partner. J Sex Med 2008;5:2587-99.